Cargando…
Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
Symptomatic interventions for patients with dementia involve anti-dementia drugs to improve cognition, psychotropic drugs for the treatment of behavioral disorders (BDs), and different categories of drugs for concomitant disorders. Demented patients may take >6–10 drugs/day with the consequent ri...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246738/ https://www.ncbi.nlm.nih.gov/pubmed/32357528 http://dx.doi.org/10.3390/ijms21093059 |